NPPB and hydrops fetalis: Adverse events were occurring directly after initiation of the treatment, persisted at 12 months and were most pronounced in patients with impaired kidney function (eGFR < 60 mL/min per1.73 m2), prior HF, and elevated baseline levels of NT-proBNP (Scirica et al., 2014).